跳至主要内容
临床试验/NCT00935870
NCT00935870已完成不适用

Bioactive Glass (S53P4) as Bone Graft Substitute in Operative Treatment of Depressed Lateral Condyle Fractures, Benign Bone Tumour Cavities and in Spinal Fusion - a 10 Years Follow-up and Bone Density Study.

Vivoxid Ltd1 个研究点 分布在 1 个国家目标入组 63 人开始时间: 2008年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
63
试验地点
1

研究概览

简要总结

The main aim is to evaluate the long-term safety and bone healing in the operated area and to compare bioactive glass granules with autogenous bone as a filler material.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

性别
All
接受健康志愿者

入选标准

  • Written informed consent obtained; Participation of previous clinical investigation with bioactive glass

排除标准

  • The subject is unlikely to adhere to study procedures
  • Concurrent disease or condition that in the opinion of the investigator is contraindicating participation
  • Simultaneous participation in another medical device or investigational drug trial

研究者

发起方
Vivoxid Ltd
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验